Breaking News

Office closed for long Easter weekend

Normal service will resume on Tuesday 23 April 2019

Russian syringe maker is looking for manufacturing site in Belarus

Ural Medical Company and other manufacturers are looking to make connections between the countries

Kiadis acquires CytoSen for synergistic immunology portfolio

CytoSen Therapeutics develops NK-cell therapy, which complements Kiadis’ T-cell therapy portfolio

The promise of manufacturing in modular cleanrooms

Maik Jornitz, G-CON Manufacturing CEO, and Dr Kevin Robinson analyse whether the cost of a cleanroom should be the ...

Gene therapy uses HIV virus to cure ‘bubble boy’ disease

Therapy has cured 10 infants with no side effects and experts hope this development template will be used for other ...

Encube Ethicals opens new topical manufacturing facility

The 205 sqm facility in Goa caters for topical products, including those containing HPAPIs

Global serialisation: Russian track and trace readiness

Christoph Krähenbühl, Senior Director of Excellis Europe, explains the challenge that the new Russian traceability ...

Lonza: Pharma Biotech & Nutrition business performs well

The Swiss CDMO keeps 2019 outlook, expects CH 7.1 billion in sales and announces measures to mitigate headwinds ...

Vetter’s Skokie facility expansion nears completion

The expansion features storage space increase of 3,100 sqft, including a freezer farm as well as a planned walk-in ...

Pilot line for nanopharmaceuticals up and running in the UK

Manufacturing capacity at CPI's NETPark site in County Durham focuses on glycan-coated gold nanoparticles for immune ...

Backend, baffling and buzzing: blockchain

Marco Mohwinckel, healthcare executive and adviser, takes a closer look at the invisible backend technology that has ...

The recurring insanity of labelling recall — and how to avoid it

We’re all familiar with Einstein’s alleged definition of insanity: doing the same thing over and over and expecting ...

CPhI North America and iBIO parnership supports women in STEM

Partnership includes US$10,000 donation to fund iBIO STEM programming for girls, plus discounted rates for iBIO members ...

Verona gets EU patent for ensifentrine formulation extended to 2035

Drug by the British company is in Phase 2b clinical trials for chronic obstructive pulmonary disease